Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: A case study with comparison to MRI

  • Regine Choe
  • , Alper Corlu
  • , Kijoon Lee
  • , Turgut Durduran
  • , Soren D. Konecky
  • , Monika Grosicka-Koptyra
  • , Simon R. Arridge
  • , Brian J. Czerniecki
  • , Douglas L. Fraker
  • , Angela Demichele
  • , Britton Chance
  • , Mark A. Rosen
  • , Arjun G. Yodh

Research output: Contribution to journalArticlepeer-review

291 Scopus citations

Abstract

We employ diffuse optical tomography (DOT) to track treatment progress in a female subject presenting with locally advanced invasive carcinoma of the breast during neoadjuvant chemotherapy. Three-dimensional images of total hemoglobin concentration and scattering identified the tumor. Our measurements reveal tumor shrinkage during the course of chemotherapy, in reasonable agreement with magnetic resonance images of the same subject. A decrease in total hemoglobin concentration contrast between tumor and normal tissue was also observed over time. The results demonstrate the potential of DOT for measuring physiological parameters of breast lesions during chemotherapy.

Original languageEnglish
Pages (from-to)1128-1139
Number of pages12
JournalMedical Physics
Volume32
Issue number4
DOIs
StatePublished - Apr 2005

Bibliographical note

Funding Information:
The authors thank J. P. Culver for his work on the instrumentation and for helpful discussions. The authors also thank L. Sherman for her contribution as clinical research assistant and Y. K. Choe for his help with illustrations. This research was supported by NIH R01-CA75124-04 and CALGB150007/150012.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Breast cancer
  • Breast imaging
  • Diffuse optical tomography
  • Near infrared imaging
  • Neoadjuvant chemotherapy

Fingerprint

Dive into the research topics of 'Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: A case study with comparison to MRI'. Together they form a unique fingerprint.

Cite this